Delcath Systems-Aktie erreicht 52-Wochen-Hoch van 12 US-Dollar van Investing.com

The Promotion of Delcath Systems Inc. (DCTH) has a brand of Meilenstein and a 52-Wochen-Hoch of 12.00 US-Dollar erzielt. This high-quality mirror is a meaningful representation of the market performance of the outdoor spaces that are wider and clearer. In the year of the sale of Delcath Systems, a managed sale of 265.89%, there was a large turnover and a robust financial company of the underlying capital. These trade initiatives will further the positive impact of Delcath’s strategic initiatives and potential waiting rooms in the market.

In other cases, Delcath Systems reported the price quotation in the quarter of 2024 with an estimated value of 11.2 million US dollars, and the Konsensschätzung of 9.5 Millionen US-Dollar deutlich übertraf. This was sold at the end of March 2024 with a scaffolding of 44% in the summer of 2024, with HC Wainwright exercising the Kaufempfehlung for the external economies. The company has now forecast that Delcath will have earned US$33.5 million by 2024, while Aktie has made a net profit of US$1.18.

Delcath Systems lost its tranche B options from a US$25 million private investment round with financing enabled. At the Unternehmen factory, the latter is used for the further commercial development of the HEPZATO KIT and investments in clinical studies that are used.

A study at the Moffitt Cancer Center and University Studies in Leipzig, Deutschland conducted a number of studies on Delcath’s HEPZATO KIT and CHEMOSAT Hepatic Delivery System in the treatment of Leberkrebs research. This knowledge has a major impact on disease control and progression-free care for patients with metastatic cutaneous melanoma and the first or second phase of life.

Schließlich plans Delcath Systems, which will provide active treatment centers by the end of 2024 from 20 to 20 and will aim to achieve a positive cash flow by the end of 2025. If there is an active action, the action will be resolved in the future.

InvestingPro Acknowledgment

The young entrepreneurial achievements of Delcath Systems Inc. (DCTH) go a step further with more knowledge and experience from InvestingPro. The company of the subdivisions is traded in the 52-Wochen-Hoch, with a price, of 93.15% of the highest percentages. This strong performance is as good as the average return on sales: 29.62% in the month, 35.9% in the lower month and a brand return of 248.41% over the year.

InvestingPro-Tipps made sure that analysts made their money for a year, the company’s first investment decision was possible. The fact that the debtor had operated with moderate indebtedness and liquid assets, while the debtor’s indebtedness had stable financial stability, was a default probability.

Please note that DCTH is trading with a high Umsatz-Multiplikator and a high Kurs-Buchwert-Verhaal of 73.07. As an entrepreneur, if you obtain a large profit margin of 350.44% in the last month of the month, it is not profitable with an operating profit margin of -303.5%.

If you analyze any of the following, you can provide InvestingPro with 14 other tips for Delcath Systems, which offers one of the financial capabilities and market position of our other companies.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.